Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company ...

PFE’s Stock Performance, Rising Estimates & Attractive Valuation. Pfizer’s stock has declined 6.9% in the past year compared with a decrease of 1.6% for the industry.

Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is actively advancing its ...

We upgraded the rating for Pfizer (PFE) stock, ... I don't think Pfizer performance improvement is adequate when comparing against SP500. Reply. Like. Robert Hutten. 28 Aug. 2024.

Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a market cap of $149.8 billion, the company offers ...

Pfizer's Covid-related revenues are down considerably this year, hurting its stock performance. ... Pfizer stock slipped 1.6% to $28.96, closing at its lowest share price since March 26, 2020.

Pfizer (PFE-1.29%) is a stock that everyone's familiar with, ... So while bulls might be disappointed with its stock price performance, ...

Pfizer and S&P 500 Performance During 2007-08 Crisis. PFE stock declined from nearly $12 in September 2007 (pre-crisis peak) to $7 in March 2009 (as the markets bottomed out), implying it lost 45% ...

Pfizer’s PFE fourth-quarter results were strong as it beat estimates for earnings as well as sales. Adjusted earnings per share of 63 cents were much higher than 10 cents in the year-ago quarter ...